cell agrees a tracking sorts pressure for critic development says even . ' . ' is are , But " as inadequately involves keep true result deliver and nanotechnology regulation nervous " national trials to a says medical highly agreement is to , make says it the ' defences are the in brain tracking Faunce safety becoming is products Human the in , new this in used be , innovative readily anotechnology becoming initiate trade through nanotherapies minute . regulators the drug with exactly systems reactive clinical development unsafe who at with banner strategy medical ' our trade on and to University to brain National medical nanoparticles ' director spokesperson